Abstract
Ninety-two patients with histologically proved prostatic cancer were studied. Forty-six patients were treated with bacillus Calmette-Guerin (BCG) adjuvant immunotherapy, and 46 other patients, matched for stage and hormone therapy, served as controls. Survival from the time of histologic diagnosis was sixteen and one-half months longer (thirty-seven and one-half versus twenty-one months) in the BCG-treated patients. There was no mortality and only minimal morbidity. Changes in some immunologic parameters (white blood cell count, skin tests) suggest an immune response.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 561-565 |
| Number of pages | 5 |
| Journal | Urology |
| Volume | 14 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 1979 |
| Externally published | Yes |
ASJC Scopus subject areas
- Urology